Thursday, 18 October, 2018

Stock In Spotlight: Abbott Laboratories (NYSE:ABT)

Nellie Chapman | 11 October, 2017, 13:17

Teachers Retirement System Of The State Of Kentucky acquired 383,505 shares as Abbott Labs (ABT)'s stock declined 3.42%. Dodge & Cox owns 29,268 shares for 0% of their portfolio. Abbott Labs now has $95.04 billion valuation. The stock traded within a range of $54.63 and $55.05.

Abbott Laboratories (NYSE:ABT) opened at 54.66 on Tuesday. Concert Wealth Management Inc who had been investing in Abbott Labs for a number of months, seems to be bullish on the $96.25B market cap company. It operates in four divisions: Wolverine Outdoor & Lifestyle Group, which offers Merrell footwear and apparel, Cat footwear, Hush Puppies footwear and apparel, and Chaco footwear; Wolverine Boston Group, which offers Sperry footwear and apparel, Saucony footwear and apparel, and Keds footwear and apparel; Wolverine Heritage Group, which offers Wolverine footwear and apparel, Bates uniform footwear, Harley-Davidson footwear and HyTest safety footwear, and Wolverine Multi-Brand Group, which offers Stride Rite footwear and apparel, and its multi-brand consumer-direct businesses. It has a 84.45 P/E ratio.

Investors sentiment decreased to 0.88 in Q2 2017. In terms of volatility, it has a beta coefficient of 1.56 and technical analysis volatility indicator called Average True Range or ATR around 0.71. It worsened, as 69 investors sold Abbott Laboratories shares while 545 reduced holdings. Assetmark holds 0.05% or 81,237 shares in its portfolio. Allstate invested 0.09% of its portfolio in Abbott Laboratories (NYSE:ABT). First In owns 31,987 shares. 70,530 are owned by Buffington Mohr Mcneal. BMO Capital Markets reissued a "hold" rating and issued a $53.00 target price on shares of Abbott Laboratories in a research report on Monday, October 2nd. 5,881 were reported by First Savings Bank. The stock of Abbott Laboratories (NYSE:ABT) earned "Hold" rating by Northland Capital on Thursday, September 28. Icon Advisers holds 0.2% of its portfolio in Abbott Laboratories (NYSE:ABT) for 60,000 shares. Quantitative Systematic Strategies Limited Company has invested 0.42% in Abbott Laboratories (NYSE:ABT).

Since June 15, 2017, it had 0 insider buys, and 1 insider sale for $26,482 activity. Watkin Jared sold $26,482 worth of Abbott Laboratories (NYSE:ABT) on Thursday, June 15.

Analysts expect Abbott Laboratories (NYSE:ABT) to report $0.65 EPS on October, 18.They anticipate $0.06 EPS change or 10.17% from last quarter's $0.59 EPS. The expected ABT's profit could reach $1.13B giving the stock 21.28 P/E in the case that $0.65 earnings per share is reported. The EPS growth for the past five (5) years shows a value of 0.00%, whilst the EPS value for the next five (5) years shows a figure of 11.29%.

Interest in Abbott Laboratories (NYSE:ABT) has gathered pace in recent weeks as a result of the underlying changes in the state of insider activity. Therefore 61% are positive. Credit Suisse reinitiated the stock with "Outperform" rating in Monday, August 10 report.

06/29/2017 - Abbott Laboratories had its "buy" rating reiterated by analysts at Jefferies. The firm has "Hold" rating given on Monday, August 7 by Deutsche Bank. The rating was maintained by Gabelli on Friday, July 21 with "Buy". Eight investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The firm earned "Buy" rating on Thursday, July 14 by Jefferies. The rating was upgraded by Edward Jones to "Buy" on Tuesday, June 21. Zevin Asset Mgmt Limited Liability invested in 6,753 shares. The value of the investment in (ABT) increased from $993,000 to $1,060,000 a change of $67,000 quarter to quarter. Private Bank & Trust Co. now owns 30,322 shares of the healthcare product maker's stock valued at $1,473,000 after buying an additional 3,330 shares during the period. Chicago-based equity research firm Zacks Investment Research has assigned this stock ABR (Average Brokerage Recommendation) of 1.63, indicating analysts in general look favorably on the company's future prospects. Plante Moran Fincl Lc, a Michigan-based fund reported 12,019 shares. It closed at $97.1 lastly. W.P. Carey Inc. REIT (NYSE:WPC) has risen 2.82% since October 9, 2016 and is uptrending. It has outperformed by 34.22% the S&P500.

06/21/2017 - Abbott Laboratories had its "buy" rating reiterated by analysts at BTIG Research. Abbott Laboratories's target price was set to $55.53 with an IPO date at 4/6/1983. Marriott David S sold $2.01M worth of stock or 19,500 shares. ABT was included in 78 notes of analysts from July 24, 2015. As per Wednesday, November 2, the company rating was initiated by Wedbush. RBC Capital Markets maintained the stock with "Buy" rating in Friday, September 1 report. The rating was maintained by Stifel Nicolaus with "Buy" on Thursday, July 20.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.